🇪🇺 INSULIN GLULISINE (HMR1964) in European Union

EMA authorised INSULIN GLULISINE (HMR1964) on 27 September 2004

Marketing authorisation

EMA — authorised 27 September 2004

  • Application: EMEA/H/C/000557
  • Marketing authorisation holder: sanofi-aventis Deutschland GmbH
  • Local brand name: Apidra
  • Indication: Treatment of adults, adolescents and children, six years or older with diabetes mellitus, where treatment with insulin is required.
  • Status: approved

Read official source →

Other Diabetes approved in European Union

Frequently asked questions

Is INSULIN GLULISINE (HMR1964) approved in European Union?

Yes. EMA authorised it on 27 September 2004.

Who is the marketing authorisation holder for INSULIN GLULISINE (HMR1964) in European Union?

sanofi-aventis Deutschland GmbH holds the EU marketing authorisation.